MCK
McKesson Corporation · Healthcare · Medical - Distribution
Momentum inputs (comparable managers):
holder breadth +5.6% ·
share flow +6.2% ·
net new positions +5.3%
— formula
Broad accumulation — rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 172 | 0 | 84.73M | $64.19B | +6 | −5 |
| Q1 2026 | 174 | 0 | 86.49M | $74.72B | +5 | −6 |
| Q4 2025 | 173 | +2 | 91.21M | $74.82B | +3 | — |
| Q3 2025 | 22 | 0 | 48.07M | $37.12B | +1 | −2 |
| Q2 2025 | 20 | -1 | 40.25M | $29.48B | — | −1 |
| Q1 2025 | 18 | -1 | 15.05M | $10.13B | +1 | −2 |
| Q4 2024 | 19 | +1 | 15.70M | $8.94B | +1 | — |
| Q3 2024 | 17 | -1 | 9.08M | $4.48B | +1 | −2 |
| Q2 2024 | 18 | — | 11.69M | $6.82B | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passive) | 5.71M | — | $3.26B | 0.1% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 2.66M | +0.4% | $1.51B | 0.1% | ▲ Add | 3 | SEC ↗ ×2 |
| 3 | Norges Bank ✦ (passive) | 2.11M | -1.8% | $1.20B | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 1.18M | -12.3% | $673.91M | 0.1% | ▼ Trim | 3 | SEC ↗ ×2 |
| 5 | Arrowstreet Capital ✦ | 928.46K | -16.4% | $529.14M | 0.4% | ▼ Trim | 3 | SEC ↗ |
| 6 | AQR Capital Management ✦ | 922.18K | +9.2% | $525.56M | 0.7% | ▲ Add | 3 | SEC ↗ ×6 |
| 7 | Marshall Wace ✦ | 358.92K | +59720.3% | $204.55M | 0.3% | ▲ Add | 3 | SEC ↗ ×3 |
| 8 | Bridgewater Associates ✦ | 329.36K | +33.8% | $187.71M | 0.9% | ▲ Add | 3 | SEC ↗ |
| 9 | D. E. Shaw & Co. ✦ | 243.35K | +238.2% | $138.69M | 0.2% | ▲ Add | 3 | SEC ↗ ×2 |
| 10 | Renaissance Technologies ✦ | 235.23K | +168.4% | $134.06M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 11 | Adage Capital Partners ✦ | 191.10K | +287.6% | $108.91M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 189.46K | +92.8% | $107.97M | 0.1% | ▲ Add | 3 | SEC ↗ ×2 |
| 13 | Millennium Management ✦ | 175.84K | +100.3% | $100.21M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 14 | Two Sigma Investments ✦ | 164.74K | +548.2% | $93.89M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 15 | Glenview Capital ✦ | 151.62K | -43.2% | $86.41M | 2.2% | ▼ Trim | 3 | SEC ↗ |
| 16 | Point72 Asset Management ✦ | 102.80K | New | $58.59M | 0.2% | New | 1 | SEC ↗ |
| 17 | Gotham Asset Management ✦ | 30.35K | +1.8% | $17.29M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 18 | Wellington Management ✦ | 9.18K | +18.2% | $5.23M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 19 | Fisher Asset Management ✦ | 923 | -25.7% | $526,316 | 0.0% | ▼ Trim | 3 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Point72 Asset Management | $58.59M | 0.2% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 2,017 holders, 102.83M shares, $85.35B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 111 sh · $98,951
Director · 301 sh · $268,590
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology